Dow Up 0.09% Nasdaq Down 0.02%

Keryx Biopharmaceuticals Inc. (KERX)

-NCM
18.18 Up 0.29(1.62%) 4:00PM EDT
|After Hours : 18.30 Up 0.12 (0.66%) 5:41PM EDT
Prev Close:17.89
Open:18.15
Bid:18.17 x 1100
Ask:18.25 x 100
1y Target Est:23.42
Beta:4.16
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:17.73 - 18.20
52wk Range:8.48 - 18.20
Volume:1,742,218
Avg Vol (3m):1,504,570
Market Cap:1.67B
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for KERX

Comparison

Symbol% ChgMkt Cap
KERXUp 1.62%1.67B
BAXDown 0.25%40.81B
SHPGDown 0.54%47.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):164.26
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.89
Quarterly EPS Est (Sep-14) :-0.27
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.67

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of renal disease in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback